Demelash Areda
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 2
-
- Respiratory viral infections research 1
- Trypanosoma species research and implications 1
Demelash Areda
38 papers receiving 13.6k citations
Demelash Areda's Hit Papers
Peers
Comparison fields: 5 of 196
- Applied Microbiology and Biotechnology 478
- Molecular Medicine 644
- Endocrinology, Diabetes and Metabolism 972
- Microbiology 370
- Health, Toxicology and Mutagenesis 627
Countries citing papers authored by Demelash Areda
This map shows the geographic impact of Demelash Areda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demelash Areda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demelash Areda more than expected).
Fields of papers citing papers by Demelash Areda
This network shows the impact of papers produced by Demelash Areda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demelash Areda. The network helps show where Demelash Areda may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2904 |
| 2 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1850 |
| 3 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 4 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 5 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 1486 |
| 6 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1105 |
| 7 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 8 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 9 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 428 |
| 10 | Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 213 |
| 11 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 12 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 13 | National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050 Hit paper breakdown → | 2024 | 165 |
| 14 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 15 | Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 118 |
| 16 | 2023 | 90 | |
| 17 | Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 86 |
| 18 | Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 76 |
| 19 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 65 |
| 20 | Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 62 |
About Demelash Areda
Demelash Areda is a scholar working on Applied Microbiology and Biotechnology, Epidemiology, Neurology, Public Health, Environmental and Occupational Health and Otorhinolaryngology, having authored 46 papers that have together received 14.0k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (2 papers), Vaccine Coverage and Hesitancy (1 paper), Ear Surgery and Otitis Media (1 paper), Energy and Environment Impacts (1 paper), Respiratory viral infections research (1 paper), Suicide and Self-Harm Studies (1 paper), Trypanosoma species research and implications (1 paper) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (478 citations), Molecular Medicine (644 citations), Endocrinology, Diabetes and Metabolism (972 citations), Microbiology (370 citations) and Health, Toxicology and Mutagenesis (627 citations). Demelash Areda has collaborated with scholars based in United States, Ethiopia and Australia. Their work appears in journals such as The Lancet, The Lancet Public Health, The Lancet Infectious Diseases, Nature Medicine and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.